These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 18474583)
21. MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor. Fraud S; Campigotto AJ; Chen Z; Poole K Antimicrob Agents Chemother; 2008 Dec; 52(12):4478-82. PubMed ID: 18838593 [TBL] [Abstract][Full Text] [Related]
22. MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections. Singh M; Yau YCW; Wang S; Waters V; Kumar A Can J Microbiol; 2017 Dec; 63(12):929-938. PubMed ID: 28922614 [TBL] [Abstract][Full Text] [Related]
23. Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime. Campo Esquisabel AB; Rodríguez MC; Campo-Sosa AO; Rodríguez C; Martínez-Martínez L Clin Microbiol Infect; 2011 Dec; 17(12):1817-22. PubMed ID: 21599797 [TBL] [Abstract][Full Text] [Related]
24. Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa. Zhao L; Wang S; Li X; He X; Jian L Antimicrob Resist Infect Control; 2020 Aug; 9(1):124. PubMed ID: 32758289 [TBL] [Abstract][Full Text] [Related]
25. Efflux pump contribution to multidrug resistance in clinical isolates of Pseudomonas aeruginosa. Kiser TH; Obritsch MD; Jung R; MacLaren R; Fish DN Pharmacotherapy; 2010 Jul; 30(7):632-8. PubMed ID: 20575627 [TBL] [Abstract][Full Text] [Related]
26. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; Martínez JL mBio; 2017 Jul; 8(4):. PubMed ID: 28743808 [TBL] [Abstract][Full Text] [Related]
27. Extrusion of penem antibiotics by multicomponent efflux systems MexAB-OprM, MexCD-OprJ, and MexXY-OprM of Pseudomonas aeruginosa. Okamoto K; Gotoh N; Nishino T Antimicrob Agents Chemother; 2002 Aug; 46(8):2696-9. PubMed ID: 12121960 [TBL] [Abstract][Full Text] [Related]
28. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin. Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417 [No Abstract] [Full Text] [Related]
29. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model. Adamson DH; Krikstopaityte V; Coote PJ J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513 [TBL] [Abstract][Full Text] [Related]
30. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype. Wolter DJ; Black JA; Lister PD; Hanson ND J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029 [TBL] [Abstract][Full Text] [Related]
31. RELATIVE EXPRESSION OF EFFLUX PUMPS IN MULTI DRUG RESISTANT PSEUDOMONAS AERUGINOSA. Azimi L; Namvar AE; Jamali S; Lari AR; Bijari A; Lari AR Roum Arch Microbiol Immunol; 2015; 74(3-4):86-90. PubMed ID: 27328522 [TBL] [Abstract][Full Text] [Related]
32. Expression of RND efflux pumps mediated antibiotic resistance in Pseudomonas aeruginosa clinical strains. Zahedi Bialvaei A; Rahbar M; Hamidi-Farahani R; Asgari A; Esmailkhani A; Mardani Dashti Y; Soleiman-Meigooni S Microb Pathog; 2021 Apr; 153():104789. PubMed ID: 33556480 [TBL] [Abstract][Full Text] [Related]
33. Induction of mexCD-oprJ operon for a multidrug efflux pump by disinfectants in wild-type Pseudomonas aeruginosa PAO1. Morita Y; Murata T; Mima T; Shiota S; Kuroda T; Mizushima T; Gotoh N; Nishino T; Tsuchiya T J Antimicrob Chemother; 2003 Apr; 51(4):991-4. PubMed ID: 12654738 [TBL] [Abstract][Full Text] [Related]
34. Purification of a 54-kilodalton protein (OprJ) produced in NfxB mutants of Pseudomonas aeruginosa and production of a monoclonal antibody specific to OprJ. Hosaka M; Gotoh N; Nishino T Antimicrob Agents Chemother; 1995 Aug; 39(8):1731-5. PubMed ID: 7486910 [TBL] [Abstract][Full Text] [Related]
35. Role of the Multidrug Resistance Efflux Pump MexCD-OprJ in the Alcalde-Rico M; Olivares-Pacheco J; Alvarez-Ortega C; Cámara M; Martínez JL Front Microbiol; 2018; 9():2752. PubMed ID: 30532741 [TBL] [Abstract][Full Text] [Related]